Valuation (33%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -89.56 | 36.60 |
| PEG Ratio (TTM) | -1.77 | 11.93 |
| P/S Ratio (TTM) | 4.78 | 14.59 |
| P/B Ratio (TTM) | 1.99 | 18.85 |
| P/FCF Ratio (TTM) | 19.33 | 42.97 |
| Price to 5YR AVG Earnings Ratio | -21.33 | 32.89 |
| Price to 5YR AVG FCF Ratio | 75.54 | 63.21 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -1.50% | 12.11% |
| ROE (TTM) | -2.30% | -8.47% |
| Net Profit Margin (TTM) | -5.55% | 24.49% |
| ROIC 5YR AVG | -9.75% | 4.06% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 63.70% | -81.24% | -35.16% |
| Revenue | 3.83% | 48.32% | 41.93% |
| Net Income | 63.57% | -104.17% | -50.43% |
| Cash Flow | 42.75% | 126.00% | 171.19% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.83 | 1.43 |
| Quick Ratio (TTM) | 1.83 | 1.42 |
| D/E Ratio (TTM) | -0.03 | 1.25 |
| Interest Coverage (TTM) | -43.33 | 35.12 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 2.37 | 9.30 |
| LTL to 5YR AVG FCF | 8.15 | 5.64 |
| Shares Outstanding Growth 5YR AVG | 8.85% | 0.66% |